Search results

Page results

• Covid-19 NHS vaccination centre opens at London’s Business Design Centre

  London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.

• Day Care Unit - The National Hospital for Neurology and Neurosurgery (NHNN)

  The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.

• Faith leaders in Islington call for everyone to be vaccinated

  “Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.

• Contrast agents for MRI examinations

  This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.

• Dr Steve Harris appointed as Chief Research Information Officer

  UCLH is delighted to announce the appointment of Dr Steve Harris as Chief Research Information Officer (CRIO).

• Botulinum toxin treatment

  This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.

• Epilepsy surgery - a guide for patients

  Neurosurgery is a treatment option for some people with epilepsy.

• Immunotherapy significantly increases the number of patients free from bowel cancer

  An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• National Day of Reflection: remembering all those we have lost during this pandemic

  Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.